# Clinical Trial to Evaluate the Ingested, Space Occupying Hydrogel Capsules for Simple Obesity Treatment

> **NCT06530017** · NA · NOT_YET_RECRUITING · sponsor: **IMEIK Technology Development Co., Ltd.** · enrollment: 440 (estimated)

## Conditions studied

- Simple Obesity

## Interventions

- **DEVICE:** Ingested, Space Occupying hydrogel capsules
- **DEVICE:** placebo

## Key facts

- **NCT ID:** NCT06530017
- **Lead sponsor:** IMEIK Technology Development Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-31
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06530017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06530017, "Clinical Trial to Evaluate the Ingested, Space Occupying Hydrogel Capsules for Simple Obesity Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06530017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*